Title: Efficacy and Safety of Nivolumab in Advanced Gastric and Gastroesophageal Junction
Cancer: A Meta-Analysis of Randomized Controlled Trials
Version: 2 Date: 22 Sep 2024
Reviewer:  Toshimitsu Tanaka
Reviewer's report:
The presented manuscript is revised adequately. The exclusion of the same studies reduced bias
as much as possible and improved the quality of the meta-study. Furthermore, the quality of this
study was also ensured by highlighting the study's limitations. Thank you for the revisions to
the points raised.
Title: Efficacy and Safety of Nivolumab in Advanced Gastric and Gastroesophageal Junction
Cancer: A Meta-Analysis of Randomized Controlled Trials
Version: 2 Date: 22 Sep 2024
Reviewer:  Toshimitsu Tanaka
Reviewer's report:
The presented manuscript is revised adequately. The exclusion of the same studies reduced bias
as much as possible and improved the quality of the meta-study. Furthermore, the quality of this
study was also ensured by highlighting the study's limitations. Thank you for the revisions to
the points raised.
Please review this paper.
user
Title: Efficacy and Safety of Nivolumab in Advanced Gastric and Gastroesophageal Junction
Cancer: A Meta-Analysis of Randomized Controlled Trials
Version: 2 Date: 22 Sep 2024
Reviewer:  Toshimitsu Tanaka
Reviewer's report:
The presented manuscript is revised adequately. The exclusion of the same studies reduced bias
as much as possible and improved the quality of the meta-study. Furthermore, the quality of this
study was also ensured by highlighting the study's limitations. Thank you for the revisions to
the points raised.
assistant